Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
2016; Springer Science+Business Media; Volume: 19; Issue: 1 Linguagem: Inglês
10.1007/s12094-016-1505-1
ISSN1699-3055
AutoresAndrea Di Cataldo, Antonella Agodi, Julia Balaguer, Alberto Garaventa, Martina Barchitta, Vanessa Segura, Maurizio Bianchi, Victoria Castel, Aurora Castellano, Simone Cesaro, José Miguel Couselo, Ofelia Cruz, Paolo D’Angelo, Bruno De Bernardi, J Donat, Nagore García de Andoín, Miguel Ángel Ibáñez-Hernández, M. La Spina, M.E. Lillo García, Ricardo López Almaraz, Roberto Luksch, Stefano Mastrangelo, Elena Mateos, José Manuel Molina, Carla Moscheo, Rosamaria Mura, Fulvio Porta, Giovanna Russo, Annalisa Tondo, Montserrat Torrent, Simona Vetrella, José Antonio Villegas Rubio, Elisabetta Viscardi, Giulio Andrea Zanazzo, Adela Cañete,
Tópico(s)Cancer therapeutics and mechanisms
Referência(s)